Cargando…
Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics
Sharks and other cartilaginous fish are the phylogenetically oldest living organisms that have antibodies as part of their adaptive immune system. As part of their humoral adaptive immune response, they produce an immunoglobulin, the so-called immunoglobulin new antigen receptor (IgNAR), a heavy-cha...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093575/ https://www.ncbi.nlm.nih.gov/pubmed/33959632 http://dx.doi.org/10.3389/fmolb.2021.639166 |
_version_ | 1783687839029919744 |
---|---|
author | Fernández-Quintero, Monica L. Seidler, Clarissa A. Quoika, Patrick K. Liedl, Klaus R. |
author_facet | Fernández-Quintero, Monica L. Seidler, Clarissa A. Quoika, Patrick K. Liedl, Klaus R. |
author_sort | Fernández-Quintero, Monica L. |
collection | PubMed |
description | Sharks and other cartilaginous fish are the phylogenetically oldest living organisms that have antibodies as part of their adaptive immune system. As part of their humoral adaptive immune response, they produce an immunoglobulin, the so-called immunoglobulin new antigen receptor (IgNAR), a heavy-chain only antibody. The variable domain of an IgNAR, also known as V(NAR), binds the antigen as an independent soluble domain. In this study, we structurally and dynamically characterized the affinity maturation mechanism of the germline and somatically matured (PBLA8) V(NAR) to better understand their function and their applicability as therapeutics. We observed a substantial rigidification upon affinity maturation, which is accompanied by a higher number of contacts, thereby contributing to the decrease in flexibility. Considering the static x-ray structures, the observed rigidification is not obvious, as especially the mutated residues undergo conformational changes during the simulation, resulting in an even stronger network of stabilizing interactions. Additionally, the simulations of the V(NAR) in complex with the hen egg-white lysozyme show that the V(NAR) antibodies evidently follow the concept of conformational selection, as the binding-competent state already preexisted even without the presence of the antigen. To have a more detailed description of antibody–antigen recognition, we also present here the binding/unbinding mechanism between the hen egg-white lysozyme and both the germline and matured V(NAR)s. Upon maturation, we observed a substantial increase in the resulting dissociation-free energy barrier. Furthermore, we were able to kinetically and thermodynamically describe the binding process and did not only identify a two-step binding mechanism, but we also found a strong population shift upon affinity maturation toward the native binding pose. |
format | Online Article Text |
id | pubmed-8093575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80935752021-05-05 Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics Fernández-Quintero, Monica L. Seidler, Clarissa A. Quoika, Patrick K. Liedl, Klaus R. Front Mol Biosci Molecular Biosciences Sharks and other cartilaginous fish are the phylogenetically oldest living organisms that have antibodies as part of their adaptive immune system. As part of their humoral adaptive immune response, they produce an immunoglobulin, the so-called immunoglobulin new antigen receptor (IgNAR), a heavy-chain only antibody. The variable domain of an IgNAR, also known as V(NAR), binds the antigen as an independent soluble domain. In this study, we structurally and dynamically characterized the affinity maturation mechanism of the germline and somatically matured (PBLA8) V(NAR) to better understand their function and their applicability as therapeutics. We observed a substantial rigidification upon affinity maturation, which is accompanied by a higher number of contacts, thereby contributing to the decrease in flexibility. Considering the static x-ray structures, the observed rigidification is not obvious, as especially the mutated residues undergo conformational changes during the simulation, resulting in an even stronger network of stabilizing interactions. Additionally, the simulations of the V(NAR) in complex with the hen egg-white lysozyme show that the V(NAR) antibodies evidently follow the concept of conformational selection, as the binding-competent state already preexisted even without the presence of the antigen. To have a more detailed description of antibody–antigen recognition, we also present here the binding/unbinding mechanism between the hen egg-white lysozyme and both the germline and matured V(NAR)s. Upon maturation, we observed a substantial increase in the resulting dissociation-free energy barrier. Furthermore, we were able to kinetically and thermodynamically describe the binding process and did not only identify a two-step binding mechanism, but we also found a strong population shift upon affinity maturation toward the native binding pose. Frontiers Media S.A. 2021-04-20 /pmc/articles/PMC8093575/ /pubmed/33959632 http://dx.doi.org/10.3389/fmolb.2021.639166 Text en Copyright © 2021 Fernández-Quintero, Seidler, Quoika and Liedl. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Fernández-Quintero, Monica L. Seidler, Clarissa A. Quoika, Patrick K. Liedl, Klaus R. Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics |
title | Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics |
title_full | Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics |
title_fullStr | Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics |
title_full_unstemmed | Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics |
title_short | Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics |
title_sort | shark antibody variable domains rigidify upon affinity maturation—understanding the potential of shark immunoglobulins as therapeutics |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093575/ https://www.ncbi.nlm.nih.gov/pubmed/33959632 http://dx.doi.org/10.3389/fmolb.2021.639166 |
work_keys_str_mv | AT fernandezquinteromonical sharkantibodyvariabledomainsrigidifyuponaffinitymaturationunderstandingthepotentialofsharkimmunoglobulinsastherapeutics AT seidlerclarissaa sharkantibodyvariabledomainsrigidifyuponaffinitymaturationunderstandingthepotentialofsharkimmunoglobulinsastherapeutics AT quoikapatrickk sharkantibodyvariabledomainsrigidifyuponaffinitymaturationunderstandingthepotentialofsharkimmunoglobulinsastherapeutics AT liedlklausr sharkantibodyvariabledomainsrigidifyuponaffinitymaturationunderstandingthepotentialofsharkimmunoglobulinsastherapeutics |